Q1 2025 Profound Medical Corp Earnings Call Transcript

May 8, 2025 / 08:30 PM GMT

Release Date Price: C$6.9 (+4.70%)

Transcript 8-K10-Q

Key Points

Positve

Profound Medical Corp (PROF) reported a significant revenue increase of 82% in Q1 2025 compared to the same period in 2024.
The company's gross margin improved to 71% in Q1 2025 from 60% in Q1 2024, indicating better cost management.
The Tulsa Pro technology demonstrated strong clinical outcomes, including no blood loss and no overnight hospital stays, enhancing patient recovery and satisfaction.
The introduction of the Tulsa AI volume reduction module is expected to significantly reduce procedure time for BPH treatments, potentially expanding the market.
Profound Medical Corp (PROF) has secured Level 7 reimbursement from CMS, which is higher than its peers, facilitating broader adoption across various healthcare settings.

Negative

Profound Medical Corp (PROF) reported a net loss of $10.7 million in Q1 2025, an increase from a $6.6 million loss in the same period in 2024.
Operating expenses rose significantly to $13 million in Q1 2025 from $8.7 million in Q1 2024, driven by increased R&D and SG&A costs.
The transition from a placement model to a capital model may result in a back-end loaded revenue recognition, potentially impacting short-term financial performance.
Despite positive clinical outcomes, the company faces challenges in converting clinical success into widespread commercial adoption.
The company's reliance on new site installations and conversions for capital revenue growth may pose risks if adoption rates do not meet expectations.

Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

PRN.TO - Profound Medical Corp
Q1 2025 Profound Medical Corp Earnings Call
May 08, 2025 / 08:30PM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Good day and thank you for standing by. Welcome to the profounded first quarter 2025 financial results conference call. At this time, all participants are in a listen-only mode. After the speaker's presentation, there will be a question and answer session. To ask a question during a session, you will need to press 11 on your telephone. You will then hear an automated message advising your hand is raised. To withdraw your question, please press 11 again. Please be advised that today's conference is being recorded. I would not like to have the conference over to your first speaker today, Stephen Kilmer, head of investor relations. Please go ahead.

--------------------------------------------------------------------------------

Already have an account? Log in

Get the full story

Subscribe Now

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

30-Day 100% money back guarantee

Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Calculators Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App Newsletters Signup 中文

Education

Financial Glossary Tutorials FAQ Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.